Peng Stanford L

See RemarksALPINE IMMUNE SCIENCES, INC. (ALPN) · full profile →Form 4 · filed May 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2024Disposed to issuer(D)296K48K
May 20, 2024Disposed to issuer(D)48K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2024Disposed to issuer(D)120K0
May 20, 2024Disposed to issuer(D)150K0
May 20, 2024Disposed to issuer(D)215K0
May 20, 2024Disposed to issuer(D)143K0
May 20, 2024Disposed to issuer(D)81K0
May 20, 2024Disposed to issuer(D)50K0
May 20, 2024Disposed to issuer(D)72K0
May 20, 2024Disposed to issuer(D)237K0
May 20, 2024Disposed to issuer(D)42K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001626199-24-000093) within minutes of acceptance. Every field above traces to the original document. Verify it directly: